PCRX Pacira BioSciences
- 25.500
- -0.400-1.54%
- 25.490
- -0.010-0.04%
Pacira BioSciences News
Pacira BioSciences | ARS: Annual Report to Security Holders
Pacira BioSciences | DEFA14A: Others
Pacira BioSciences | DEF 14A: Definitive information statements
Pacira BioSciences | 4: Statement of changes in beneficial ownership of securities-Director PACE GARY W
Pacira BioSciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Pacira BioSciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Pacira BioSciences | 10-K: Annual report
Pacira BioSciences | 8-K: Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
Pacira BioSciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(10.98%)
Pacira BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer WILLIAMS KRISTEN
Pacira BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer GAUGLER DARYL
Pacira BioSciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(17.5%)
Pacira BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer SLONIN JONATHAN
Pacira BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer RIKER LAUREN
Pacira BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer Lee Frank D.
Pacira BioSciences | 3: Initial statement of beneficial ownership of securities-Officer Lee Frank D.
Pacira BioSciences | 8-K: Current report
Pacira BioSciences | 8-K: Current report
Pacira BioSciences | 3: Initial statement of beneficial ownership of securities-Officer SLONIN JONATHAN
Pacira BioSciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Analysis
Price Target
No Data
